19:57:28 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-04-29 Årsstämma 2025
2025-04-29 Kvartalsrapport 2025-Q1
2025-02-28 Bokslutskommuniké 2024
2024-10-31 Kvartalsrapport 2024-Q3
2024-07-31 Kvartalsrapport 2024-Q2
2024-04-30 Ordinarie utdelning NNH 0.00 SEK
2024-04-29 Årsstämma 2024
2024-04-29 Kvartalsrapport 2024-Q1
2024-02-28 Bokslutskommuniké 2023
2023-10-31 Kvartalsrapport 2023-Q3
2023-07-31 Kvartalsrapport 2023-Q2
2023-04-28 Ordinarie utdelning NNH 0.00 SEK
2023-04-27 Kvartalsrapport 2023-Q1
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-29 Kvartalsrapport 2022-Q2
2022-04-29 Ordinarie utdelning NNH 1.25 SEK
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-28 Årsstämma 2022
2022-02-28 Bokslutskommuniké 2021
2021-10-29 Kvartalsrapport 2021-Q3
2021-07-30 Kvartalsrapport 2021-Q2
2021-04-30 Ordinarie utdelning NNH 1.50 SEK
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-29 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-10-30 Kvartalsrapport 2020-Q3
2020-07-31 Kvartalsrapport 2020-Q2
2020-04-30 Ordinarie utdelning NNH 1.75 SEK
2020-04-29 Kvartalsrapport 2020-Q1
2020-04-29 Årsstämma 2020
2020-02-28 Bokslutskommuniké 2019
2019-10-31 Kvartalsrapport 2019-Q3
2019-07-31 Kvartalsrapport 2019-Q2
2019-04-29 Ordinarie utdelning NNH 1.50 SEK
2019-04-25 Kvartalsrapport 2019-Q1
2019-04-25 Årsstämma 2019
2019-03-01 Bokslutskommuniké 2018
2018-10-31 Kvartalsrapport 2018-Q3
2018-07-31 Kvartalsrapport 2018-Q2
2018-04-27 Ordinarie utdelning NNH 1.15 SEK
2018-04-26 Kvartalsrapport 2018-Q1
2018-04-26 Årsstämma 2018
2018-03-02 Bokslutskommuniké 2017
2017-10-31 Kvartalsrapport 2017-Q3
2017-07-31 Kvartalsrapport 2017-Q2
2017-04-28 Ordinarie utdelning NNH 0.40 SEK
2017-04-27 Kvartalsrapport 2017-Q1
2017-04-27 Årsstämma 2017
2017-03-06 Bokslutskommuniké 2016
2016-10-31 Kvartalsrapport 2016-Q3
2016-07-29 Kvartalsrapport 2016-Q2
2016-04-29 Ordinarie utdelning NNH 0.25 SEK
2016-04-28 Årsstämma 2016
2016-04-28 Kvartalsrapport 2016-Q1
2016-03-07 Bokslutskommuniké 2015
2015-10-30 Kvartalsrapport 2015-Q3
2015-07-31 Kvartalsrapport 2015-Q2
2015-04-30 Ordinarie utdelning NNH 0.00 SEK
2015-04-29 Kvartalsrapport 2015-Q1
2015-04-29 Årsstämma 2015
2015-03-06 Bokslutskommuniké 2014
2014-10-31 Kvartalsrapport 2014-Q3
2014-07-31 Kvartalsrapport 2014-Q2
2014-05-01 Ordinarie utdelning NNH 0.00 SEK
2014-04-30 Årsstämma 2014
2014-03-07 Bokslutskommuniké 2013
2013-10-31 Kvartalsrapport 2013-Q3
2013-07-31 Kvartalsrapport 2013-Q2
2013-04-30 Ordinarie utdelning NNH 0.00 SEK
2013-04-29 Årsstämma 2013
2013-04-29 Kvartalsrapport 2013-Q1
2013-03-08 Bokslutskommuniké 2012
2012-10-31 Kvartalsrapport 2012-Q3
2012-07-31 Kvartalsrapport 2012-Q2
2012-05-01 Ordinarie utdelning NNH 0.00 SEK
2012-04-30 Årsstämma 2012
2012-04-30 Kvartalsrapport 2012-Q1
2012-03-09 Bokslutskommuniké 2011
2011-10-31 Kvartalsrapport 2011-Q3
2011-07-29 Kvartalsrapport 2011-Q2
2011-04-29 Kvartalsrapport 2011-Q1
2011-04-29 Årsstämma 2011
2011-03-11 Bokslutskommuniké 2010
2010-10-29 Kvartalsrapport 2010-Q3
2010-07-30 Kvartalsrapport 2010-Q2
2010-05-03 Ordinarie utdelning NNH 0.00 SEK
2010-04-30 Kvartalsrapport 2010-Q1
2010-02-26 Bokslutskommuniké 2009
2009-10-30 Kvartalsrapport 2009-Q3
2009-07-31 Kvartalsrapport 2009-Q2
2009-04-30 Kvartalsrapport 2009-Q1
2009-04-16 Årsstämma 1
2009-04-14 Ordinarie utdelning NNH 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHandel & varor
IndustriDetaljhandel
New Nordic Healthbrands är specialiserat mot att utveckla och marknadsföra kosttillskott och naturläkemedel. Största delen av sortimentet utgörs av hälsofrämjande örter. Produkterna säljs via bolagets återförsäljare och tillskotten används exempelvis inom hud- och hårvård, för förbättring av immunsystemet och synförmågan, samt som generella vitamintillskott. Huvudkontoret ligger i Malmö.
2017-04-27 09:01:42

Q1 2017

  • Net sales amounted to MSEK 80.9 (74.6), an increase of 8 percent. In local currencies, the increase was 6 percent.
  • Gross margin increased to 67.4 percent (63.8).
  • EBITDA increased to MSEK 5.1 (4.3).
  • Operating profit increased to MSEK 4.0 (2.8).
  • Profit after tax for the period increased to MSEK 2.9 (2.3).
  • Earnings per share increased to SEK 0.67 (0.52).

COMMENTS BY KARL KRISTIAN BERGMAN JENSEN, CEO

We had a flying start of the year.

Revenue increased 6 percent in local currencies. After converting to Swedish kronor, revenue increased by more than 8 percent and amounted to SEK 80.9 million. The organic growth in revenue is a result of effective marketing and successful product innovations.

We increased sales in the Nordic region and the rest of Europe, while we in North America had a decrease in sales. The decline in North America does not reflect a decrease in consumer sales but rather to changes in inventory levels of at major wholesalers. The comparison with last year's sales in North America is also significantly affected by last year's high sale to Costco Canada - a chain of membership warehouses.

We had a good growth in vitality, beauty and diet products, but we have challenges in our new Sport Nutrition series.

The gross margin rose satisfactorily to 67.4 percent. Sales and general expenses increased by 6 million, most of which were attributable to increased marketing costs. With low financing and depreciation costs, we achieved a profit after tax of SEK 2.9 million corresponding to SEK 0.47 per share.

The high sales and gross margin per employee is evidence of an effective organization and business structure. Our costs are well under control. Our financial position is good and we can finance our planned growth ourselves.

We will continue to focus on marketing and innovation to drive organic growth. Our innovation will be focused on strengthening our major product brands and satisfying both European and North American consumer needs. We plan to launch New Nordic via pharmacies in Switzerland and Hong Kong within the next 3 to 6 months and introduce our online store to Chinese consumers during the summer.

All employees are motivated and work focused on implementing our growth plans. I am convinced that 2017 will be a good year for New Nordic and its shareholders.

Malmö April 27, 2017

Karl Kristian Bergman Jensen, CEO

The information in this press release is that which New Nordic Healthbrands AB (publ) is required to disclose under Sweden's Secu- rities Market Act. and made public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 9.00 (CET) on April 27th, 2017.

Contact:

Karl Kristian Bergman Jensen, CEO +46 40-239520 (switchboard),

Marinus Blåbjerg Sørensen, CFO +45 46323344 (switchboard)

New Nordic Healthbrands AB (publ), SE-211 43 Malmö, Sweden Phone +46-40-239520, fax: +46-40-239522, email: kk@newnordic.com. Registered office: Malmö, Reg. No. 556698-0453.

The following documents can be retrieved from beQuoted
New Nordic Interim Report Q1 2017.pdf
New Nordic Pressrelease 2017-04-27.pdf
New Nordic Delarsrapport Q1 2017.pdf

New Nordic Healthbrands AB (publ) was founded in 1990 and is quoted on NASDAQ OMX Stockholm since 2007. The company's business concept is to offer the most effective and safe food supplements and natural medicines for specific health conditions. New Nordic's branded products are now available in 33 countries in pharmacies and health stores. The New Nordic Group has it's own small sales and marketing companies in most European Countries, Canada and the US, to organize local marketing campaigns, serve the pharmacy and health retailers and serve the end consumers. In 2016, sales were 306 MSEK. All New Nordic products sold worldwide are manufactured in Scandinavia. For further information, visit www.newnordic.com.